Getting trusted, helpful information about cutaneous lymphoma can be a challenge. Whether you're a patient, loved one, medical professional or supporter of our work, you've been touched by cutaneous lymphoma.
Getting trusted, helpful information about cutaneous lymphoma can be a challenge. Whether you’re a patient, loved one, medical professional or supporter of our work, you’ve been touched by cutaneous lymphoma. Along the way, you’ve probably looked for an all-inclusive, handy resource to turn to for questions or information about the disease and how to get help.
And, if you’re a healthcare provider or someone who cares for patients, you’ve probably been looking for something like this that you can share with your patients.
The Patient’s Guide to Understanding Cutaneous Lymphoma, published by the Cutaneous Lymphoma Foundation (CLF), features in-depth information about cutaneous lymphoma, treatment options, what it’s like to live with the disease and how patients can maintain the best quality of life possible. The comprehensive guide is designed for patients, caregivers, and others affected by cutaneous lymphoma and includes vital information for your patients on such topics as patient assistance programs, research and clinical trials, CLF programs, resources, and support.
To download the guide and for more information, visit: http://www.clfoundation.org/resources/patients-guide-to-understanding-cutaneous-lymphoma.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.